
About
Synovo is a preclinical CRO and drug discovery company based in Tübingen, Germany. It runs studies in inflammation, immunology, metabolic disease, CNS, and oncology for drug discovery partners.
Services
Disease Models
Runs in vivo efficacy models across inflammation, neurodegeneration, metabolic disease, and oncology with defined readouts and flexible study design.
In Vitro Assays
Performs cell-based and biochemical assays for cytokine profiling, apoptosis, cytotoxicity, cytometry, and related screening work.
PK & Tox Studies
Designs and runs pharmacokinetic, ADME, formulation, and in vivo toxicology studies in rodent and other species.
ADME, DMPK & toxicology
Medicinal Chemistry
Provides hit-to-lead and lead optimization with integrated SAR design, custom synthesis, and formulation development.
Analytics & Bioanalysis
Offers LC-MS/MS bioanalysis, bioanalytical method development, and clinical chemistry across plasma and tissue matrices.
Histology
Provides immunohistochemistry, image analysis, and quantitative digital pathology for tissue and immune characterization.
- Lead time
- Respond within one business day
Capabilities
As they state on their website or in their listing.
- Processes
- Antibody
- Bioanalysis
- Rodent models
- Flow cytometry
- LC-MS/MS
- PK/PD
3 more
- In vivo
- Histopathology
- Biochemical assays
- Capacity
- Three sites in Tübingen
- Around 40 scientists
- Offers
- Custom synthesis
- Data supplied
- LC-MS
Equipment
- ZE5 five-laser platform
- Respons 910 analyzer
Materials
- Mouse
- Rat
- Rabbit
- Pig / minipig
- Guinea pig / hamster
- Primary human cells
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
Details
- Type
- CRO
- Founded
- 2004
- Team
- Around 40 scientists
- Based in
- Tübingen, Germany
- General enquiry
- contact@synovo.com on their site
Public records
- Parent company
- Synovo GmbH · DE GLEIF